|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/19 | |
| A61K 31/7042 | |||
| A61P 19/06 |
| (11) | Patento numeris | 2968235 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14717246.4 |
| Europos patento paraiškos padavimo data | 2014-03-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/020958 |
| Data | 2014-03-06 |
| (87) | Numeris | WO 2014/149789 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361786738 P | 2013-03-15 | US |
| (72) |
ROTHENBERG, Paul, US
WAYS, Douglas., K, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREATMENT OF HYPERURICEMIA |
| COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREATMENT OF HYPERURICEMIA |